Eversept Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,000
| Closed | -$9.27M | – | 82 |
|
|
2024
Q2 | $9.27M | Buy |
+100,000
| New | +$9.27M | 0.63% | 27 |
|
|
2023
Q4 | – | Sell |
-20,000
| Closed | -$1.46M | – | 70 |
|
|
2023
Q3 | $1.46M | Buy |
+20,000
| New | +$1.46M | 0.12% | 55 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 75 |
|
|
2023
Q1 | – | Sell |
-216,087
| Closed | -$17.9M | – | 75 |
|
|
2022
Q4 | $17.9M | Buy |
216,087
+116,087
| +116% | +$9.64M | 1.57% | 14 |
|
|
2022
Q3 | $7.93M | Sell |
100,000
-256,067
| -72% | -$20.3M | 0.69% | 27 |
|
|
2022
Q2 | $26.4M | Buy |
+356,067
| New | +$26.4M | 1.88% | 11 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 99 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 115 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 113 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 91 |
|